Screener
Dyne Therapeutics, Inc. DYN Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net loss | $(120,854) | $(115,361) |
| Net loss per share—basic and diluted | $(0.73) | $(1.05) |
| Weighted average common shares outstanding, basic and diluted | 165,036,604 | 109,911,628 |
| Comprehensive loss: | ||
| Net loss | $(120,854) | $(115,361) |
| Other comprehensive loss: | ||
| Unrealized gains (losses) on marketable securities, net | (612) | 235 |
| Comprehensive loss | $(121,466) | $(115,126) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Dyne Therapeutics, Inc. (DYN) reported comprehensive income (loss), net of tax, attributable to parent of -$121.47M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 5.5% year-over-year, from -$115.13M to -$121.47M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 31.4% compound annual growth rate (CAGR), from -$149.53M to -$445.75M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources during the period, encompassing both net income and other comprehensive income items such as unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance by including items that bypass the traditional income statement. Investors use this to evaluate the total impact of all financial activities on the company's net worth.
Ask your AI about Dyne Therapeutics, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude